Vascular Adviser Podcast
Subscribe in ParasocialFree on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
The audio files provided on the Thrombosis Adviser channel are intended for viewers outside the USA and the UK only. Thrombosis Adviser is an online resource for physicians and patients about current and emerging therapies for thromboembolic disease including venous thrombosis (VTE), atrial fibrillation (AF), and acute coronary syndrome (ACS). The Thrombosis Adviser podcast series is intended to provide information to HPCs. Imprint Published by: Bayer AG, Leverkusen, Germany represented by the Management Board: Werner Baumann, Chairman Bill Anderson, Sarena Lin, Wolfgang Nickl, Stefan Oelrich, Rodrigo Kaiser-Wilhelm-Allee 1 51373 Leverkusen, Germany Tel.: +49 (0)214 30-1 E-mail: Inquiries can be sent to info@bayer.com...
Also on
Recent episodes
- XARENO 2 - Year Data - Expert Podcast With Manesh Patel And Peter Rossing
- The beginning of the end for NOACs? The extra mile
- Extended anticoagulation in patients with VTE: The importance of patient preference
- What does the XARENO study mean for our patients with atrial fibrillation and kidney disease?
- Anticoagulation in cardiology: Protecting what matters for your patients with VTE
- EHRA 2022 - Expert Podcast With John Camm And Keith Fox
- Preserving limbs and avoiding repeat revascularization in patients with PAD
- Treatment of cancer-associated thrombosis: What is the evidence for rivaroxaban?
- Evolving Cardiovascular Risk: Your Patient’s Past, Present and Future
- Preserving Limbs And Avoiding Repeat Revascularization In Patients With PAD